Related Experiment Video
Updated: Aug 6, 2026
06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Current and future therapies for ischemic cerebrovascular disease
K Yanaka1, Y Kujiraoka, M Okazaki
1Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
Drugs of Today (Barcelona, Spain : 1998)
|July 8, 2003
Summary
Urgent treatments for ischemic stroke are needed. Recent advances in pharmacological interventions, including tissue plasminogen activator (t-PA) and neuroprotective agents, offer new hope for minimizing brain damage and improving patient outcomes.
Area of Science:
- Neurology
- Pharmacology
Background:
- Stroke is a leading cause of adult death and disability.
- Effective treatments for ischemic stroke are urgently required.
- Current management focuses on acute interventions and managing long-term consequences.
Purpose of the Study:
- To highlight recent advancements in pharmacological treatments for ischemic stroke.
- To discuss emerging therapies aimed at minimizing ischemic brain damage.
- To review strategies for arterial recanalization, neuronal protection, and host response inhibition.
Main Methods:
- Review of current literature on ischemic stroke treatments.
- Focus on pharmacologic interventions based on pathophysiologic research.
- Discussion of tissue plasminogen activator (t-PA) and neuroprotective agents.
Main Results:
- Tissue plasminogen activator (t-PA) is a key emergent treatment for selected patients within 3 hours of stroke onset.
- Numerous neuroprotective agents have been developed.
- New therapies are emerging to potentially reduce ischemic brain damage.
Conclusions:
- Pharmacological interventions are crucial for managing ischemic stroke.
- Ongoing research is yielding promising new therapeutic strategies.
- Advances aim to improve survival and reduce the debilitating effects of stroke.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...